High Risk, High Reward for the Magnificent Seven High Expectations for Earnings Season The Roundhill Magnificent Seven ETF (MAGS) climbed 15.2% in... Read More →
In-Network Stocks for OZEM Originally developed for diabetes treatment, the discovery of GLP-1 therapeutics as a weight loss... Read More →
Roundhill Roundup - The “Winner Takes All” Market With major indexes hitting all-time high after all-time high, you would think investors would be... Read More →
A Response to "There Is No Magnificent Seven" On June 14, 2024, Allan Sloan published a commentary in Barron’s with the headline “There Is No... Read More →
Roundhill Roundup: Markets Go Up Last year, a knock on the market was its lack of breadth, whereby a small number of names were... Read More →